Insilico Medicine names Nirav Jhaveri as CFO

Insilico Medicine, an end-toend artificial intelligence (AI)powered drug discovery company based in the US and China, has announced the appointment of Nirav Jhaveri as Chief Financial Officer (CFO) to oversee capital markets, investor relations, financial operations, and corporate development. Jhaveri brings two decades of capital markets, business development and biopharma experience.

Before joining Insilico, he served as CFO of Journey Medical Corporation, a commercial-stage biopharmaceutical company, where he was responsible for business development, corporate strategy and capital raising. Prior to Journey Medical, Jhaveri was Vice President, Business Development, at Fortress Biotech. Earlier in his career, he held roles in equity research at Citigroup and investment banking at Bank of America.